Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance
- PMID: 12019095
- PMCID: PMC127250
- DOI: 10.1128/AAC.46.6.1816-1822.2002
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance
Abstract
Susceptibility to macrolides and lincosamides was investigated with 299 consecutive nonduplicate Streptococcus pyogenes clinical isolates collected over a 6-year period (1992 to 1997) from an area of central Italy. During this period, macrolide resistance rates steadily increased (from 9% in 1992 to 53% in 1997; P < 0.001). The increase was caused by isolates with a macrolide-lincosamide-streptogramin B resistance phenotype, carrying mostly erm(B) but also erm(TR) genes, that were not detected in the first 2 years and were detected with increasing prevalence (8, 5, 26, and 37%, respectively) during the following 4 years. During the same period, the prevalence of isolates with a macrolide resistance phenotype, carrying mef(A) determinants, did not vary significantly; on average it was 13%, with modest rate fluctuations in different years and no definite trend. Molecular typing revealed a remarkable clonal diversity among susceptible and resistant isolates and a notable heterogeneity of the genetic environment of the resistance genes. The analysis of clonal diversity in relation with resistance phenotypes and genotypes revealed that increased macrolide resistance rates were due to a complex interplay of different mechanisms, with a relevant contribution played by an "epidemic" spread of genetic elements carrying the erm(B) gene among the circulating streptococcal population.
Figures

Similar articles
-
Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes.Microb Drug Resist. 2002 Summer;8(2):129-32. doi: 10.1089/107662902760190671. Microb Drug Resist. 2002. PMID: 12118517
-
Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).J Antimicrob Chemother. 2016 Aug;71(8):2113-7. doi: 10.1093/jac/dkw116. Epub 2016 Apr 26. J Antimicrob Chemother. 2016. PMID: 27118782
-
Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.Antimicrob Agents Chemother. 2004 Jul;48(7):2716-8. doi: 10.1128/AAC.48.7.2716-2718.2004. Antimicrob Agents Chemother. 2004. PMID: 15215133 Free PMC article.
-
Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.Expert Rev Anti Infect Ther. 2015 May;13(5):615-28. doi: 10.1586/14787210.2015.1023292. Epub 2015 Mar 8. Expert Rev Anti Infect Ther. 2015. PMID: 25746210 Review.
-
An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics.Microorganisms. 2022 Nov 23;10(12):2316. doi: 10.3390/microorganisms10122316. Microorganisms. 2022. PMID: 36557569 Free PMC article. Review.
Cited by
-
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.PLoS One. 2010 Mar 24;5(3):e9836. doi: 10.1371/journal.pone.0009836. PLoS One. 2010. PMID: 20352091 Free PMC article.
-
Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.mSphere. 2018 Apr 18;3(2):e00103-18. doi: 10.1128/mSphere.00103-18. Print 2018 Apr 25. mSphere. 2018. PMID: 29669883 Free PMC article. Clinical Trial.
-
Genetic basis of erythromycin resistance in oral bacteria.Antimicrob Agents Chemother. 2004 Jun;48(6):2298-301. doi: 10.1128/AAC.48.6.2298-2301.2004. Antimicrob Agents Chemother. 2004. PMID: 15155239 Free PMC article.
-
Prevalence of M75 Streptococcus pyogenes Strains Harboring slaA Gene in Patients Affected by Pediatric Obstructive Sleep Apnea Syndrome in Central Italy.Front Microbiol. 2017 Feb 28;8:294. doi: 10.3389/fmicb.2017.00294. eCollection 2017. Front Microbiol. 2017. PMID: 28293224 Free PMC article.
-
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.Infection. 2009 Aug;37(4):353-7. doi: 10.1007/s15010-008-8023-1. Epub 2008 Dec 5. Infection. 2009. PMID: 19137242
References
-
- Baquero, F., J. A. Garcia-Rodríguez, J.G. de Lomas, L. Aguilar, and The Spanish Surveillance Group for Respiratory Pathogens. 1999. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob. Agents Chemother. 43:178-180. - PMC - PubMed
-
- Bisno, A. L., and D. S. Stevens. 2000. Streptococcus pyogenes, p. 2101-2116. In G. L. Mandell, J. E. Bennet, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed. Churchill Livingstone, Inc., New York, N.Y.
-
- Caillaud, F., C. Carlier, and P. Courvalin. 1987. Physical analysis of the conjugative shuttle transposon Tn1545. Plasmid 17:58-60. - PubMed
-
- Chassy, B. M. 1976. A gentle method for the lysis of oral streptococci. Biochem. Biophys. Res. Commun. 68:603-608. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical